2018
DOI: 10.1007/s00540-018-2491-y
|View full text |Cite
|
Sign up to set email alerts
|

Accuracy and trending ability of the fourth-generation FloTrac/Vigileo System™ in patients undergoing abdominal aortic aneurysm surgery

Abstract: The degree of accuracy of the fourth-generation FloTrac/Vigileo™ in patients with AAA surgery was not acceptable. The tracking ability of the fourth-generation FloTrac/Vigileo™ after aortic clamp was below the acceptable limit.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…When compared to other minimally or non-invasive techniques used in clinical practice, most devices show a MPE of more than 30% [10,12,[68][69][70][71][72][73][74][75][76]. Therefore, Peyton and Chong have suggested to change the acceptable MPE to 45%, ensuring a higher rate of agreement in new methods [12].…”
Section: Summary Of Evidencementioning
confidence: 99%
“…When compared to other minimally or non-invasive techniques used in clinical practice, most devices show a MPE of more than 30% [10,12,[68][69][70][71][72][73][74][75][76]. Therefore, Peyton and Chong have suggested to change the acceptable MPE to 45%, ensuring a higher rate of agreement in new methods [12].…”
Section: Summary Of Evidencementioning
confidence: 99%
“…Another study tested the fourth-generation FloTrac™ algorithm in patients undergoing abdominal aortic aneurysm surgery and also found a low bias and high percentage error (bias 0.4 L min −1 ; percentage error 46.7%) of CO measurements [25]. The concordance rate for trending ability was 26.9% before and after aortic clamping and 47.3% before and after first unclamping of the iliac artery.…”
Section: Discussionmentioning
confidence: 99%
“…The device has been proven to accurately track changes in cardiac output when preload changes [41]. On the other hand, current evidence still shows conflicting results on the FloTrac technology: the system still lacks optimal accuracy and trending ability in cardiac and vascular surgery, and the discrepancy in cardiac output measurement depends on the peripheral vascular tone [42,43]. The FloTrac 4-th generation software used in our study is both more accurate and more precise even when phenylephrine in low-moderate doses are administered [44].…”
Section: Discussionmentioning
confidence: 99%